Increased risk of digoxin toxicity following hospitalization

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 1, 2009, Pages 28-35

  Haynes, Kevin ^a   Hennessy, Sean ^a   Localio, A Russell ^a   Cohen, Abigail ^a   Leonard, Charles E ^a   Kimmel, Stephen E ^a   Feldman, Harold I ^a   Strom, Brian L ^a   Metlay, Joshua P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adverse effects; Drug toxicity; Physician patient relationships

Indexed keywords

DIGOXIN; CARDIOTONIC AGENT;

AGED; ARTICLE; COHORT ANALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EXPOSURE; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE MANAGEMENT; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; INCIDENCE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PHARMACY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SIDE EFFECT; AGE; CLINICAL PRACTICE; POISSON DISTRIBUTION; POVERTY; PROSPECTIVE STUDY; STATISTICS; TIME; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; COHORT STUDIES; DIGOXIN; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; PENNSYLVANIA; PHYSICIAN'S PRACTICE PATTERNS; POISSON DISTRIBUTION; POVERTY; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 59049094203     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1680     Document Type: Article

References (21)

1. Hennessy S. Potentially remediable features of the medication-use environment in the United States. Am J Health Syst Pharm 2000; 57: 543-548.
2. Bochner F, Tonkin A. The clinician and therapeutic drug monitoring in the 1990s. Med J Aust 1993; 158: 422-426.
3. Hussain Z, Swindle J, Hauptman PJ. Digoxin use and digoxin toxicity in the post-DIG trial era. J Card Fail 2006; 12: 343-346.
4. Budnitz DS, Shehab N, Kegler SR, et al. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147: 755-765.
5. Metlay JP, Cohen A, Polsky D, et al. Medication safety in older adults: home-based practice patterns. J Am Geriatr Soc 2005; 53: 976-982.
6. Ware JE, Kosinski M, Dewey JE, Gandek B. How to Score and Interpret Single-Item Health Measures: A Manual for Users of the SF-8 Health Survey. Lincoln(RI): Quality Metric Inc: 2001.
7. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.
8. Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry 1999; 14: 936-940.
9. Burke WJ, Roccaforte WH, Wengel SP, et al. The reliability and validity of the Geriatric Depression Rating Scale administered by telephone. J Am Geriatr Soc 1995; 43: 674-679.
10. Sharp LK, Lipsky MS. Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician 2002; 66: 1001-1008.
11. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854-864.
12. Rea TD, Siscovick DS, Psaty BM, et al. Digoxin therapy and the risk of primary cardiac arrest in patients with congestive heart failure: effect of mild-moderate renal impairment. J Clin Epidemiol 2003; 56: 646-650.
13. Pahor M, Guralnik JM, Gambassi G, et al. The impact of age on risk of adverse drug reactions to digoxin. For The Gruppo Italiano di Farmacovigilanza nell' Anziano. J Clin Epidemiol 1993; 46: 1305-1314.
14. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-1968.
15. Forster AJ, Murff HJ, Peterson JF, et al. Adverse drug events occurring following hospital discharge. J Gen Intern Med 2005; 20: 317-323.
16. Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006; 61: 511-515.
17. Mahdyoon H, Battilana G, Rosman H, et al. The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J 1990; 120: 1189-1194.
18. Williamson KM, Thrasher KA, Fulton KB, et al. Digoxin toxicity: an evaluation in current clinical practice. Arch Intern Med 1998; 158: 2444-2449.
19. Haynes K, Heitjan D, Kanetsky P, et al. Declining public health burden of digoxin toxicity from 1991 to 2004. Clin Pharmacol Ther 2007; DOI: 10.1038/sj.clpt.6100458
20. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997; 45: 945-948.
21. Kripalani S, Jackson AT, Schnipper JL, et al. Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med 2007; 2: 314-323.